GRNAW Stock

Profile

Full Name:

GreenLight Biosciences Holdings

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Website:

http://greenlightbiosciences.com

Description:

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$6.38 M(+100.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

-347.58%

Annual Debt To Equity

1.67

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with GRNAW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price All-time High

$0.53
GRNAW price is currently at an all-time high

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+112.73%
GRNAW annual revenue is up +112.73% over the past 3 years

Annual Net Income 3-Year Change

-483.11%
GRNAW annual net profit is down -483.11% over the past 3 years

Annual Operating Profit

-$162.96 M
GRNAW annual operaing income is -$162.96 million

Annual Operating Profit 3-Year Change

-458.04%
GRNAW annual operaing income is down -458.04% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

-347.58%
GRNAW annual return on equity is -347.58%

Annual ROA

-112.42%
GRNAW annual return on assets is -112.42%

Annual EBIT

-$161.84 M
GRNAW annual earnings before interest & taxes is -$161.84 million

Annual EBITDA

-$153.99 M
GRNAW annual earnings before interest, taxes, depreciation & amortization is -$153.99 million

Annual Interest Coverage Ratio

-39.25
GRNAW annual interest coverage ratio is -39.25

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

2.01
GRNAW annual current ratio is 2.01

Annual Total Assets

$148.60 M
GRNAW annual total assets is $148.60 million

Annual Current Assets

$71.31 M
GRNAW annual total current assets is $71.31 million

Annual Total Liabilities

$100.54 M
GRNAW annual total liabilities is $100.54 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-433.36%
GRNAW annual cash flow from operations is down -433.36% over the past 3 years

Annual CFI 3-Year Change

-1298.21%
GRNAW annual cash flow from investing activities is down -1298.21% over the past 3 years

Annual CFF 3-Year Change

+1408.34%
GRNAW annual cash flow from financing activities is up +1408.34% over the past 3 years

Annual CAPEX

$26.55 M
GRNAW annual capital expenditures is $26.55 million

Annual CAPEX 3-Year Change

+1300.16%
GRNAW annual capital expenditures is up +1300.16% over the past 3 years

Annual FCF

-$163.28 M
GRNAW annual free cash flow is -$163.28 million

Annual FCF 3-Year Change

-493.05%
GRNAW annual free cash flow is down -493.05% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of GreenLight Biosciences Holdings?
  • What is the ticker symbol for GreenLight Biosciences Holdings?
  • Does GreenLight Biosciences Holdings pay dividends?
  • What sector is GreenLight Biosciences Holdings in?
  • What industry is GreenLight Biosciences Holdings in?
  • What country is GreenLight Biosciences Holdings based in?
  • Is GreenLight Biosciences Holdings in the S&P 500?
  • Is GreenLight Biosciences Holdings in the NASDAQ 100?
  • Is GreenLight Biosciences Holdings in the Dow Jones?
  • When does GreenLight Biosciences Holdings report earnings?

What is the primary business of GreenLight Biosciences Holdings?

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

What is the ticker symbol for GreenLight Biosciences Holdings?

The ticker symbol for GreenLight Biosciences Holdings is NASDAQ:GRNAW

Does GreenLight Biosciences Holdings pay dividends?

No, GreenLight Biosciences Holdings does not pay dividends

What sector is GreenLight Biosciences Holdings in?

GreenLight Biosciences Holdings is in the Healthcare sector

What industry is GreenLight Biosciences Holdings in?

GreenLight Biosciences Holdings is in the Biotechnology industry

What country is GreenLight Biosciences Holdings based in?

GreenLight Biosciences Holdings is headquartered in United States

Is GreenLight Biosciences Holdings in the S&P 500?

No, GreenLight Biosciences Holdings is not included in the S&P 500 index

Is GreenLight Biosciences Holdings in the NASDAQ 100?

No, GreenLight Biosciences Holdings is not included in the NASDAQ 100 index

Is GreenLight Biosciences Holdings in the Dow Jones?

No, GreenLight Biosciences Holdings is not included in the Dow Jones index

When does GreenLight Biosciences Holdings report earnings?

The date for GreenLight Biosciences Holdings's next earnings report has not been announced yet